Risk Factors and Predictive Models for Intravenous Immunoglobulin Resistance in Children with Recurrent Kawasaki Disease
Xi Chen,Lu Gao,Zhen Zhen,Ying Wang,Jia Na,Wen Yu,Xinyuan Chu,Yue Yuan,Suyun Qian
DOI: https://doi.org/10.2147/jir.s360802
IF: 4.5
2022-05-06
Journal of Inflammation Research
Abstract:Xi Chen, 1 Lu Gao, 1 Zhen Zhen, 1 Ying Wang, 1 Jia Na, 1 Wen Yu, 1 Xinyuan Chu, 1 Yue Yuan, 1 Suyun Qian 2 1 Department of Cardiology, Beijing Children's Hospital, Capital Medical University, National Center for Children's Health, Beijing, 100045, People's Republic of China; 2 Pediatric Intensive Care Unit, Beijing Children's Hospital, Capital Medical University, National Center for Children's Health, Beijing, 100045, People's Republic of China Correspondence: Yue Yuan, Department of Cardiology, Beijing Children's Hospital, Capital Medical University, National Center for Children's Health, No. 56, Nanlishilu, District Xicheng, Beijing, 100045, People's Republic of China, Email ; Suyun Qian, Pediatric Intensive Care Unit, Beijing Children's Hospital, Capital Medical University, National Center for Children's Health, No. 56, Nanlishilu, District Xicheng, Beijing, 100045, People's Republic of China, Email ; Purpose: To explore the risk factors and develop predictive models for intravenous immunoglobulin (IVIG) resistance in children with recurrent Kawasaki disease (KD). Patients and Methods: Patients with recurrent KD were retrospectively reviewed. Clinical and laboratory data at recurrence were collected and compared between patients with and without IVIG resistance. The patients were randomly divided into training and validation cohorts for model development and validation. All variables were subjected to standard Lasso and its variant group Lasso analyses, respectively, to construct predictive models. Model performance was evaluated by receiver operating characteristics (ROC) curves, calibration curves, and Hosmer-Lemeshow tests. Results: A total of 90 children with recurrent KD were included. A total of 16 cases were IVIG resistant. The patients with IVIG resistance had higher age and IVIG resistance probability at the first episode, increased CRP levels, neutrophil count, neutrophil percentage, direct bilirubin level, prothrombin time, and international normalized ratio, and decreased lymphocyte count, lymphocyte percentage, and serum sodium levels. Five variables including age and IVIG resistance at the first episode, lymphocytes count, serum sodium levels, and CRP levels were finally selected by standard Lasso (lLasso model) and four variables including age and IVIG resistance at the first episode, neutrophil percentage, and CRP levels were selected by group Lasso (gLasso). ROC curves suggested lLasso and gLasso models had similar excellent discrimination in both the training cohort (0.895 vs 0.906) and the validation cohort (0.855 vs 0.909). Hosmer-Lemeshow tests suggested the two models exerted a good calibration. Two nomograms were also constructed to facilitate the potential application of the two models. Conclusion: Age and IVIG resistance at the first episode and some laboratory variables may be risk factors for IVIG resistance in recurrent KD. Two predictive models for IVIG resistance with excellent performance were established in recurrent KD. External validation should be performed before clinical use. Keywords: recurrent Kawasaki disease, intravenous immunoglobulin, resistance, risk factor, predictive model Kawasaki disease (KD) is an acute and systemic vasculitis, predominantly affecting children under 5 years. 1 Systemic inflammatory response plays a crucial role in KD development and progression. 2 Coronary artery lesions (CALs) are the most significant complications of this disease, leading to KD being the main cause of acquired heart diseases in developed countries. 3 Previous studies suggested the KD incidence, with an increasing trend and a marked geographic variation, is expected to be higher in Asian countries compared to western countries. 4 Similarly, the rate of KD recurrence is higher in certain Asian countries, such as Japan and Korea (3–4%) 5–7 while lower in Caucasian population in US and Canada (1.5–1.7%). 8,9 Sudo et al have analyzed the data from a nationwide survey in Japan to compare the incidence rates of recurrent KD between different years and identify that it has remained largely unchanged over the past 30 years. 5 The etiology of KD as well as its recurrence remains elusive. It seems to result from the interplay of genetic and environmental susceptibility factors with infectious triggers. 10 High-dose intravenous immunoglobulin (IVIG) combined with aspirin is the current most effective therapy. 11 Timely initiating IVIG treatment remarkably reduces the rate of CALs from 25% to 4%. 11 However, approximately 10% to 20% of KD patients are resistant to IVIG treatment and are at -Abstract Truncated-
immunology